Citius Pharmaceuticals (CTXR) Goodwill & Intangibles (2014 - 2026)

Citius Pharmaceuticals (CTXR) has 13 years of Goodwill & Intangibles data on file, last reported at $9.3 million in Q1 2026.

• Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (changed 0.0% YoY) and the FY2025 annual result came in at $9.3 million, changed 0.0% from the prior year.
• Goodwill & Intangibles retreated to $9.3 million in Q1 2026, from $82.2 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $82.2 million in Q4 2025 to a low of $9.3 million in Q1 2022.
• A 5-year average of $13.6 million and a median of $9.3 million in 2022 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles changed 0.0% — and 2025, when it surged 779.16%.
• Tracing CTXR's Goodwill & Intangibles over 5 years: stood at $9.3 million in 2022, then changed by 0.0% to $9.3 million in 2023, then changed by 0.0% to $9.3 million in 2024, then surged by 779.16% to $82.2 million in 2025, then plunged by 88.63% to $9.3 million in 2026.
• The last three Goodwill & Intangibles figures came in at $9.3 million (Q1 2026), $82.2 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.